CMIC：2021年亚洲之门：日本和韩国的市场准入白皮书（英文版）

asia offers rich opportunities forpharmaceutical companies seekingalternatives to the mature markets inNorth America or Europe. Two essentialpillars of the region are japan and South Korea.Both have been progressively opening up to theglobalization of the pharmaceutical industry.That has lowered market access barriers whilepositioning japan and South Korea as gatewaysto more comprehensive expansion in Asia. Thiswhite paper addresses recent market access andregulatory developments in the two c